ArticleHaematologica2013
Ponatinib as targeted therapy for FGFR1 fusions associated with the 8p11 myeloproliferative syndrome.
Andrew Chase et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
32 papers cite it
this papercites it
ArticleHaematologica2013
Andrew Chase et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.